CONCORDANCE IN PERCEPTIONS OF THE IMPACT OF SUBCUTANEOUS BELIMUMAB TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS BETWEEN PATIENTS AND THEIR PHYSICIANS: A CROSS-SECTIONAL, REAL-WORLD SURVEY